Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.53, p.384-392, 2006 |
||
Title: Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells | ||
Author: J., DURAJ ; J., BODO ; M., SULIKOVA ; P., RAUKO ; J., SEDLAK ; | ||
Abstract: Naturally occuring dietary compound resveratrol (RES), possessing
chemopreventive and cytostatic properties, has been
shown as potent sensitizer for apoptosis induced by a variety of
anticancer drugs. Cell cycle analysis in sensitive
promyelocytic leukemia HL60 cell line and its multidrug-resistant
variant HL60/VCR (P-gp positive) treated with RES resulted
in cell cycle arrest in S-phase in both cell variants. Flow
cytometry measurements showed diverse activities of RES in
combination with anticancer drugs doxorubicin (DOX), cycloheximide
(CHX), busulfan (BUS), gemcitabine (GEM) and
paclitaxel (PTX), in some cases resulting in apoptosis induction,
preferentially at the expense of S-phase. Thus, RES could
become a candidate to enhance the efficacy of combination
anticancer therapy in a variety of human cancer cells inclusive
leukemias.
|
||
Keywords: human leukemia cells, resveratrol (RES), anticancer drugs, combination treatments, cell cycle, flow cytometry | ||
Year: 2006, Volume: 53, Issue: | Page From: 384, Page To: 392 | |
|
download file |
|